Interpretation of do-not-resuscitate order appears to vary among pediatric physicians

Clinicians use the do-not-resuscitate (DNR) order not only as a guide for therapeutic decisions during a cardiopulmonary arrest but also as a surrogate for broader treatment directives, according to a study in JAMA Pediatrics by Amy Sanderson M.D., of Boston Children's Hospital, M.A., and colleagues.

A total of 107 physicians and 159 nurses responded to a survey regarding their attitudes and behaviors about DNR orders for . There was substantial variability in the interpretation of the DNR order. Most clinicians (66.9 percent) reported that they considered that a DNR order indicated limitation of resuscitative measures only on cardiopulmonary arrest. In reality, however, more than 85 percent reported that care changes beyond response to cardiopulmonary arrest, varying from increased attention to comfort to less clinician . In addition, most clinicians reported that resuscitation status discussions take place later in the illness course than is ideal, according to the study results.

"Interventions aimed at improving clinician knowledge and skills in discussions as well as the development of orders that address overall goals of care may improve care for children with serious illness," the study concludes.

More information: JAMA Pediatr. Published online August 26, 2013. DOI: 10.1001/jamapediatrics.2013.2204

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Want kids to eat better? Get them cooking

Nov 27, 2014

(HealthDay)—Getting kids involved in the kitchen, through cooking classes or at home, may make them more likely to choose healthy foods, according to a recent review.

Life-saving promise in simple steps

Nov 27, 2014

The debate over the best time to clamp a baby's umbilical cord has been around forever. In about 350 BCE, Aristotle, reputedly the world's first genuine scientist, advocated delaying clamping until placenta ...

PCV13 recommended for 6- to 18-year-olds at high risk

Nov 26, 2014

(HealthDay)—Pneumococcal conjugate vaccine 13 (PCV13) should be administered to certain children aged 6 through 18 years who are at high risk of invasive pneumococcal disease (IPD), according to a policy ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.